Your browser doesn't support javascript.
loading
Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction.
Kwon, Sung Pil; Hwang, Byung-Hee; Park, Eun-Hye; Kim, Han Young; Lee, Ju-Ro; Kang, Mikyung; Song, Seuk Young; Jung, Mungyo; Sohn, Hee Su; Kim, Eunmin; Kim, Chan Woo; Lee, Kwan Yong; Oh, Gyu Chul; Choo, Eunho; Lim, Songhyun; Chung, Yeonseok; Chang, Kiyuk; Kim, Byung-Soo.
Afiliação
  • Kwon SP; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Hwang BH; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Park EH; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Kim HY; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Lee JR; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kang M; Interdisciplinary Program for Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Song SY; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Jung M; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Sohn HS; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Kim E; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Kim CW; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Lee KY; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Oh GC; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Choo E; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Lim S; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Chung Y; Laboratory of Immune Regulation, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
  • Chang K; Cardiovascular Research Institute for Intractable Disease, Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Kim BS; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Small ; 17(32): e2101207, 2021 08.
Article em En | MEDLINE | ID: mdl-34216428

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Insuficiência Cardíaca / Infarto do Miocárdio Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Insuficiência Cardíaca / Infarto do Miocárdio Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article